RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Patricia Mendonca to Chemokine CCL2

Back to Details
This is a "connection" page, showing publications Patricia Mendonca has written about Chemokine CCL2.
Patricia Mendonca
Connection Strength
1.036
Chemokine CCL2
  1. Mendonca P, Horton A, Bauer D, Messeha S, Soliman KFA. The inhibitory effects of butein on cell proliferation and TNF-a-induced CCL2 release in racially different triple negative breast cancer cells. PLoS One. 2019; 14(10):e0215269.
    View in: PubMed
    Score: 0.582
  2. Kanga KJW, Mendonca P, Soliman KFA, Ferguson DT, Darling-Reed SF. Effect of Diallyl Trisulfide on TNF-a-induced CCL2/MCP-1 Release in Genetically Different Triple-negative Breast Cancer Cells. Anticancer Res. 2021 Dec; 41(12):5919-5933.
    View in: PubMed
    Score: 0.168
  3. Messeha SS, Zarmouh NO, Mendonca P, Cotton C, Soliman KFA. Molecular mechanism of gossypol mediating CCL2 and IL-8 attenuation in triple-negative breast cancer cells. Mol Med Rep. 2020 08; 22(2):1213-1226.
    View in: PubMed
    Score: 0.152
  4. Messeha SS, Zarmouh NO, Mendonca P, Alwagdani H, Kolta MG, Soliman KFA. The inhibitory effects of plumbagin on the NF-?B pathway and CCL2 release in racially different triple-negative breast cancer cells. PLoS One. 2018; 13(7):e0201116.
    View in: PubMed
    Score: 0.133
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support